About US
Contact us
-
BioLineRx signs licensing deal with Israeli institutions for type 1 diabetes treatmentBioLineRx has entered into an exclusive licensing agreement with three Israel-based institutions for the development and commercialisation of BL-9020 antibody treatment for patients with type 1 diabet2013/10/25
-
CFDA Assistant Minister Sun Xianze meets Vice President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of PolandOn October 17, 2013, Sun Xianze, Assistant Minister of China Food and Drug Administration (CFDA), met with the delegation led by Mr. Marcin Kołakowski, Vice President of the Office for Registrati2013/10/24
-
ViiV Healthcare files new drug application for three-drug HIV pill with US FDAViiV Healthcare, a joint venture involving GlaxoSmithKline (GSK), Pfizer and Shionogi, has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its investigational s2013/10/24
-
Ablynx grants licence to Eddingpharm for anti-RANKL Nanobody development in Greater ChinaBelgian biotech firm Ablynx has granted a licence to a China-based Eddingpharm to develop and commercialise its anti-RANKL Nanobody, ALX-0141, in parts of South East Asia for conditions such as osteop2013/10/23
-
Astellas' prostate-cancer prodigy Xtandi shines as pre-chemo treatmentSoon afterXtandihit the market last year, analysts were figuring that theprostate cancerdrug would help pump up that market to $9.1 billion by 2021. Already, the drug from Medivation ($MDVN) andAstell2013/10/23
-
Health Canada Approves Levemir FlexTouch Prefilled Insulin Pen for the Treatment of Type 1 and Type 2 DiabetesNovo Nordiskhas announced thatHealth Canada has approved Levemir FlexTouch, a disposable prefilled insulin pen containing Levemir (insulin detemir). Levemir FlexTouch has been designed to improve ease2013/10/22
-
GSK and Genmab seek FDA approval for ofatumumab combination therapy for CLL first-line treatmentGlaxoSmithKline (GSK) and Genmab have submitted a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) seeking the use of Arzerra (ofatumumab) in combination2013/10/22
-
1M fake Xanax pills intercepted on their way to Egypt from ChinaHow much do 1 millionXanaxpills weigh? About 400 kilograms (880 pounds), according to the drug regulator Swissmedic, which discovered 1 million counterfeit Xanax pills on a jet headed fromChinatoEgypt2013/10/21
-
Pfizer gets European approval for label update of pneumococcal conjugate vaccine Prevenar 13Pfizer has received European Commission approval for updates to the summary of product characteristics (SmPC) for its pneumococcal conjugate vaccine (PCV) Prevenar 13, regarding its use in certain hig2013/10/21
-
Safety group flags bleeding reports on Pradaxa, Xarelto and old standby warfarinThe Institute for Safe Medication Practices (ISMP) has flagged its latest set of side-effect reports to the FDA--and once again,anticoagulantdrugs are at the top.BoehringerIngelheim'sPradaxa, a new-ge2013/10/18